I’m sure it’s a pipe dream but I wish CSL could exploit Trump hoped for business friendliness and deregulation by taking over Grifols. Grifols bought Talecris which CSL was knocked back from buying by the FTC in 2009. Grifols is currently ultra cheap , market cap of some EUR5bn hence recent Brookfield interest. I fear some PE firm is not going to let this opportunity pass by . Be far better with a trade buyer ie. CSL.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$240.21 |
Change
1.500(0.63%) |
Mkt cap ! $116.3B | |||
| Open | High | Low | Value | Volume |
| $238.71 | $241.05 | $237.37 | $567.1M | 2.283M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1607 | $240.17 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $240.25 | 394 | 1 |
View Market Depth
| Last trade - 16.10pm 20/06/2025 (20 minute delay) ? |
| CSL (ASX) Chart |